300404 Stock Overview
Boji Medical Technology Co., Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Boji Medical Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.31 |
| 52 Week High | CN¥12.88 |
| 52 Week Low | CN¥5.03 |
| Beta | -0.049 |
| 1 Month Change | -2.01% |
| 3 Month Change | -4.69% |
| 1 Year Change | -27.91% |
| 3 Year Change | -18.32% |
| 5 Year Change | -23.44% |
| Change since IPO | 86.68% |
Recent News & Updates
Shareholder Returns
| 300404 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 9.8% | -1.5% | -0.3% |
| 1Y | -27.9% | -39.0% | -14.6% |
Return vs Industry: 300404 exceeded the CN Life Sciences industry which returned -39% over the past year.
Return vs Market: 300404 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 300404 volatility | |
|---|---|
| 300404 Average Weekly Movement | 11.0% |
| Life Sciences Industry Average Movement | 9.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300404's share price has been volatile over the past 3 months.
Volatility Over Time: 300404's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,186 | Tingchun Wang | www.bojicro.com |
Boji Medical Technology Co., Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, product test, pilot test scale-up, process verification batch production, and drug registration and approval services.
Boji Medical Technology Co.,Ltd. Fundamentals Summary
| 300404 fundamental statistics | |
|---|---|
| Market cap | CN¥2.78b |
| Earnings (TTM) | CN¥29.11m |
| Revenue (TTM) | CN¥619.96m |
95.9x
P/E Ratio4.5x
P/S RatioIs 300404 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300404 income statement (TTM) | |
|---|---|
| Revenue | CN¥619.96m |
| Cost of Revenue | CN¥418.51m |
| Gross Profit | CN¥201.44m |
| Other Expenses | CN¥172.33m |
| Earnings | CN¥29.11m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.076 |
| Gross Margin | 32.49% |
| Net Profit Margin | 4.70% |
| Debt/Equity Ratio | 11.8% |
How did 300404 perform over the long term?
See historical performance and comparison